查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1641788

全球內視鏡消毒化學品市場（按產品類型和最終用戶）- 機會分析和產業預測，2024-2033 年

Endoscope Disinfection Chemicals Market By Product Type (Glutaraldehyde, Peracetic Acid, Others) , By End User (Hospital and Clinics, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 239 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

內視鏡消毒化學品市場

內視鏡消毒化學品市場-IMG1

內視鏡消毒化學品市場預計在 2023 年達到 8 億美元，到 2033 年將達到 12 億美元，2024 年至 2033 年的複合年成長率為 4.2%。

內視鏡是一種管狀醫療設備，用於在診斷和手術過程中觀察中空器官的內部。內視鏡的消毒是一個非常重要的過程，因為它們直接與體液接觸。用於醫療器械消毒的化學品根據其消毒程度分為高效、中效和低效消毒劑。常用的內視鏡消毒化學物質包括戊二醛、過氧乙酸、碘磷和季銨化合物。

內視鏡檢查和微創手術的快速成長對用於對醫療設備進行消毒同時保持其品質和功能的化學品的需求日益成長。因此，重複使用內視鏡可實現一致的消毒，從而增加內視鏡消毒化學品市場的成長。此外，醫院和其他醫療機構是傳染性微生物的中心，這是市場的主要驅動力。這是因為，對醫療設備，特別是與患者身體直接接觸的設備進行適當的消毒，對於預防醫院內感染至關重要。最近，可以在幾分鐘內對內視鏡進行消毒的新製劑取得了顯著的進展。製造商正在將幾種高級消毒劑與自動化處理設備結合起來，對內視鏡進行消毒，並提高工作流程效率。

然而，對長期使用這些化學物質所帶來的健康和環境危害的擔憂正在阻礙市場的發展。相反，化學消毒與其他滅菌方法的結合將為內視鏡消毒化學品市場開闢新的途徑。例如，蒸氣滅菌器製造商Matachana表示，結合環氧乙烷、過氧化氫等離子體、低溫蒸氣和甲醛的優點，可以對內視鏡進行深度消毒。

部分回顧

內視鏡消毒化學品市場根據產品類型、最終用戶和地區進行細分。根據產品類型，市場分為戊二醛、過氧乙酸和其他。根據最終用戶，市場分為醫院/診所、門診手術中心和其他。按地區分析，涵蓋北美、歐洲、亞太、拉丁美洲以及中東和非洲。

主要發現

根據產品類型，預計戊二醛將在預測期內佔據市場主導地位。

根據最終用戶，醫院和診所部門預計將在 2024 年至 2033 年期間佔據最大佔有率。

按地區分類，預計到 2033 年北美將創造最高收益。

可以自訂此報告（可能需要支付額外的費用和時間表）。

  • 監管指南
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的額外分析 - 市場規模和預測
  • 平均售價分析/價格分佈分析
  • 擴展公司簡介列表
  • 歷史市場資料
  • Excel 格式的主要企業詳細資料（包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 重大投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會

第 4 章內視鏡消毒化學品市場（依產品類型）

  • 市場概況
  • 戊二醛
  • 過氧乙酸
  • 其他

第 5 章內視鏡消毒化學品市場（依最終用戶）

  • 市場概況
  • 醫院和診所
  • 門診手術中心
  • 其他

6. 內視鏡消毒化學品市場（按地區）

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國視鏡消毒化學品市場
    • 加拿大內視鏡消毒化學品市場
    • 墨西哥內視鏡消毒化學品市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國內視鏡消毒化學品市場
    • 法國內視鏡消毒化學品市場
    • 英國視鏡消毒化學品市場
    • 義大利內視鏡消毒化學品市場
    • 西班牙內視鏡消毒化學品市場
    • 其他歐洲國家消毒化學品市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本內視鏡消毒化學品市場
    • 中國內視鏡消毒化學品市場
    • 印度內視鏡消毒化學品市場
    • 澳洲內視鏡消毒化學品市場
    • 韓國內視鏡消毒化學物質市場
    • 其他亞太內視鏡消毒化學品市場
  • 拉丁美洲、中東和非洲
    • 主要市場趨勢和機遇
    • 巴西內視鏡消毒化學品市場
    • 沙烏地阿拉伯內視鏡消毒化學品市場
    • 南非內視鏡消毒化學品市場
    • 拉丁美洲其他地區、中東和非洲內視鏡消毒化學品市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品映射
  • 競爭儀錶板
  • 競爭熱圖
  • 2023年主要企業的定位

第8章 公司簡介

  • STERIS
  • Olympus Corporation
  • Getinge AB
  • Borer Chemie AG
  • Micro-Scientific, LLC.
  • Medalkan
  • Cantel Medical Corp.
  • Ecolab
  • Fortive Corporation
  • SteelcoBelimed AG
簡介目錄
Product Code: A324000

Endoscope Disinfection Chemicals Market

Endoscope Disinfection Chemicals Market - IMG1

The endoscope disinfection chemicals market was valued at $0.8 billion in 2023 and is projected to reach $1.2 Billion by 2033, growing at a CAGR of 4.2% from 2024 to 2033.

An endoscope is a tubular medical device used to visualize the interior of hollow organs during diagnostic and surgical procedures. The disinfection of these devices is a significantly important process as they come in direct contact with the body fluids. The chemicals used to disinfect the medical device are categorized on the basis of their disinfection levels into high-level, intermediate-level, and low-level disinfectants. Examples of commonly used endoscope disinfection chemicals include glutaraldehyde, peracetic acid, iodophors, and quaternary ammonium compounds.

Exponential increase in the number of endoscopies and minimally invasive surgeries has boosted the demand for chemicals that sterilize medical equipment while maintaining their quality and functionality. Therefore, the recurrent use of endoscopes leads to consistent disinfection, which augments the growth of the endoscope disinfection chemicals market. Furthermore, hospitals and other healthcare facilities are a hub for infectious microorganisms, and this acts as a key driver of the market. This is attributed to the fact that adequate disinfection of medical devices, specifically the ones that come in direct contact with patients' bodies, becomes crucial for the prevention of nosocomial infections. In recent times, the development of new formulations that disinfect endoscopes within minutes is a prominent trend in the market. Manufacturers incorporate several high-level disinfectants, which are used with automated processors to sterilize the endoscopes and improve workflow efficiency.

However, concerns regarding the health hazards and environmental impact associated with the long-term usage of these chemicals hamper the development of the market. On the contrary, the combination of chemical disinfection with other forms of sterilization is poised to open new avenues for the endoscope disinfection chemicals market. For instance, according to Matachana-a manufacturer of steam sterilization equipment-blending the benefits of ethylene oxide, hydrogen peroxide plasma, and low-temperature steam & formaldehyde offers deep disinfection of endoscopes.

Segment Review

The endoscope disinfection chemicals market is segmented into product type, end user, and region. On the basis of product type, the market is divided into glutaraldehyde, peracetic acid, and others. As per end user, it is categorized into hospital & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the glutaraldehyde segment is expected to dominate the market during the forecast period.

As per end user, the hospital & clinics segment is projected to be the highest shareholder from 2024 to 2033.

Region wise, North America is anticipated to be the highest revenue generator by 2033.

Competition Analysis

The leading players operating in the global endoscope disinfection chemicals market include STERIS, Olympus Corporation, Getinge AB, Borer Chemie AG, Micro-Scientific, LLC, Medalkan, Cantel Medical Corp., Ecolab, Fortive Corporation, and SteelcoBelimed AG. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product Type

  • Glutaraldehyde
  • Peracetic Acid
  • Others

By End User

  • Hospital and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • STERIS
    • Olympus Corporation
    • Getinge AB
    • Borer Chemie AG
    • Micro-Scientific, LLC.
    • Medalkan
    • Cantel Medical Corp.
    • Ecolab
    • Fortive Corporation
    • SteelcoBelimed AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ENDOSCOPE DISINFECTION CHEMICALS MARKET, BY PRODUCT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product Type
  • 4.2. Glutaraldehyde
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Peracetic Acid
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: ENDOSCOPE DISINFECTION CHEMICALS MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospital And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ambulatory Surgical Centers
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ENDOSCOPE DISINFECTION CHEMICALS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Product Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Endoscope Disinfection Chemicals Market
      • 6.2.5.1. Market Size and Forecast, By Product Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Endoscope Disinfection Chemicals Market
      • 6.2.6.1. Market Size and Forecast, By Product Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Endoscope Disinfection Chemicals Market
      • 6.2.7.1. Market Size and Forecast, By Product Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Product Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Endoscope Disinfection Chemicals Market
      • 6.3.5.1. Market Size and Forecast, By Product Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Endoscope Disinfection Chemicals Market
      • 6.3.6.1. Market Size and Forecast, By Product Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Endoscope Disinfection Chemicals Market
      • 6.3.7.1. Market Size and Forecast, By Product Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Endoscope Disinfection Chemicals Market
      • 6.3.8.1. Market Size and Forecast, By Product Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Endoscope Disinfection Chemicals Market
      • 6.3.9.1. Market Size and Forecast, By Product Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest Of Europe Endoscope Disinfection Chemicals Market
      • 6.3.10.1. Market Size and Forecast, By Product Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Product Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Endoscope Disinfection Chemicals Market
      • 6.4.5.1. Market Size and Forecast, By Product Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Endoscope Disinfection Chemicals Market
      • 6.4.6.1. Market Size and Forecast, By Product Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Endoscope Disinfection Chemicals Market
      • 6.4.7.1. Market Size and Forecast, By Product Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. Australia Endoscope Disinfection Chemicals Market
      • 6.4.8.1. Market Size and Forecast, By Product Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Endoscope Disinfection Chemicals Market
      • 6.4.9.1. Market Size and Forecast, By Product Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Endoscope Disinfection Chemicals Market
      • 6.4.10.1. Market Size and Forecast, By Product Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Product Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Endoscope Disinfection Chemicals Market
      • 6.5.5.1. Market Size and Forecast, By Product Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Endoscope Disinfection Chemicals Market
      • 6.5.6.1. Market Size and Forecast, By Product Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Endoscope Disinfection Chemicals Market
      • 6.5.7.1. Market Size and Forecast, By Product Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Endoscope Disinfection Chemicals Market
      • 6.5.8.1. Market Size and Forecast, By Product Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping Of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. STERIS
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Olympus Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Getinge AB
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Borer Chemie AG
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Micro-Scientific, LLC.
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Medalkan
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Cantel Medical Corp.
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Ecolab
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Fortive Corporation
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. SteelcoBelimed AG
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments